Maria K. Zaldivia

Melbourne, VIC, Australia

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 12 publications

Smooth Muscle Cell-Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO-cGMP Signaling.

Smooth Muscle Cell-Derived Fibronectin Promotes an Atheroprotective Smooth Muscle Cell Phenotype Associated With Altered NO-cGMP Signaling.

Journal: Journal of the American Heart Association

Published: May 29, 2025

Single-cell analysis identifies the CNP/GC-B/cGMP axis as marker and regulator of modulated VSMCs in atherosclerosis.

Single-cell analysis identifies the CNP/GC-B/cGMP axis as marker and regulator of modulated VSMCs in atherosclerosis.

Journal: Nature communications

Published: March 25, 2024

Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.

Pharmacological Inhibition of Factor XIIa Attenuates Abdominal Aortic Aneurysm, Reduces Atherosclerosis, and Stabilizes Atherosclerotic Plaques.

Journal: Thrombosis and haemostasis

Published: October 07, 2021

Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress-Induced, Piezo-1-Mediated Monocyte Activation.

Transcatheter Aortic Valve Implantation Represents an Anti-Inflammatory Therapy Via Reduction of Shear Stress-Induced, Piezo-1-Mediated Monocyte Activation.

Journal: Circulation

Published: July 23, 2020

Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.

Plasma levels of trimethylamine-N-oxide can be increased with 'healthy' and 'unhealthy' diets and do not correlate with the extent of atherosclerosis but with plaque instability.

Journal: Cardiovascular research

Published: November 24, 2019

Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability.

Lysophosphatidylcholine is a Major Component of Platelet Microvesicles Promoting Platelet Activation and Reporting Atherosclerotic Plaque Instability.

Journal: Thrombosis and haemostasis

Published: August 06, 2019

Successful renal denervation decreases the platelet activation status in hypertensive patients.

Successful renal denervation decreases the platelet activation status in hypertensive patients.

Journal: Cardiovascular research

Published: August 12, 2018

The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.

The bidirectional interaction between the sympathetic nervous system and immune mechanisms in the pathogenesis of hypertension.

Journal: British journal of pharmacology

Published: March 02, 2018

Platelet-Derived Microvesicles in Cardiovascular Diseases.

Platelet-Derived Microvesicles in Cardiovascular Diseases.

Journal: Frontiers in cardiovascular medicine

Published: August 03, 2017

A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology.

A Unique Recombinant Fluoroprobe Targeting Activated Platelets Allows In Vivo Detection of Arterial Thrombosis and Pulmonary Embolism Using a Novel Three-Dimensional Fluorescence Emission Computed Tomography (FLECT) Technology.

Journal: Theranostics

Published: October 26, 2016

Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk.

Renal Denervation Reduces Monocyte Activation and Monocyte-Platelet Aggregate Formation: An Anti-Inflammatory Effect Relevant for Cardiovascular Risk.

Journal: Hypertension (Dallas, Tex. : 1979)

Published: August 30, 2016

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.

Phosphorothioate backbone modifications of nucleotide-based drugs are potent platelet activators.

Journal: The Journal of experimental medicine

Published: February 04, 2015

Showing 1-12 of 12

Last Updated: 09/26/2026